Anti-Müllerian hormone (AMH) follows a broad arc across a woman’s life: it rises through childhood, peaks somewhere around the mid-twenties, and then steadily falls until it becomes undetectable near menopause. A large population study found that the median AMH at age 25 is roughly 3.0 ng/mL, dropping to about 0.3 ng/mL by age 44.1PubMed. Population-based age-specific reference percentiles and Z-scores for AMH in women But that single-number trajectory hides a surprising amount of individual variation, and understanding what AMH actually reflects, how different factors shift it, and what it can and cannot tell you about fertility is where the real usefulness of the test emerges.
What AMH Actually Measures
AMH is produced by the granulosa cells surrounding small growing follicles in the ovaries, specifically the preantral and small antral follicles that have been recruited from the dormant primordial pool. It does not come from the primordial follicles themselves, which means AMH does not directly count your total remaining eggs. Instead, it reflects the size of the pool of follicles currently in the early growth phase.2Nature. AMH regulates granulosa cell function via ESR2/ p38-MAPK signaling pathway in sheep That distinction matters: a woman with a large primordial reserve but relatively few follicles being recruited at a given moment could have a lower AMH than expected. AMH is best understood as a proxy for ovarian reserve rather than an exact inventory of it.
The Childhood and Adolescent Rise
AMH is detectable from birth in girls, but levels are relatively low during infancy. A systematic review reported mean values of about 10.5 pmol/L in infancy, rising to around 22.3 pmol/L during childhood, and reaching roughly 31.8 pmol/L by adolescence.3PubMed. Biomarkers of ovarian reserve in childhood and adolescence: A systematic review A long-term Danish study that tracked individual girls from infancy through adolescence confirmed that concentrations rose steadily at each stage: median AMH went from about 14 pmol/L in infancy to roughly 24.5 pmol/L in adolescence.4The Lancet. Individual trajectories of serum anti-Müllerian hormone in healthy girls from infancy to adolescence: a long-term longitudinal study
Puberty introduces a temporary dip. One longitudinal study found AMH appeared to decrease between ages 10 and 14, then rose again through age 16.5Fertility and Sterility Reports. Longitudinal antimüllerian hormone and its correlation with pubertal milestones That dip likely reflects hormonal shifts during puberty rather than any real loss of ovarian reserve. An encouraging finding from the Danish study is that a girl’s relative rank among her peers remains remarkably stable: girls who started with high AMH stayed high, and those who started low stayed low, with very little crossing of trajectories from infancy all the way to adolescence.6The Lancet. Individual trajectories of serum anti-Müllerian hormone in healthy girls from infancy to adolescence: a long-term longitudinal study This suggests that where you sit on the AMH spectrum is partly set early in life.
Adult Reference Ranges
After the early-twenties peak, AMH begins its long downward slope. A widely cited clinical guideline places conservative lower limits of age-appropriate AMH at roughly 3.0 ng/mL for age 25, 2.5 ng/mL for age 30, 1.5 ng/mL for age 35, 1.0 ng/mL for age 40, and 0.5 ng/mL for age 45.7American Journal of Obstetrics and Gynecology. Contemporary ovarian reserve tests: a review – Section: Age-specific AMH values A large cohort study of nearly 23,000 women found that by age 36, the median AMH had already fallen below 1.2 ng/mL, and that the rate of diminished ovarian reserve climbed from about 16% among 18-year-olds to nearly 96% by age 45.8PubMed Central. Age-stratified anti-Müllerian hormone (AMH) nomogram: a comprehensive cohort study including 22.920 women
These numbers are guidelines, not verdicts. The spread between women of the same age is enormous. A 35-year-old might have an AMH anywhere from below 1 ng/mL to above 4 ng/mL and still fall within the range of “normal.” That wide distribution is exactly why age-specific percentiles exist: they allow a clinician to compare your result to what is typical for women your age rather than to a single cutoff that ignores age entirely.
The Acceleration After 40
AMH does not drop at a constant rate. A large population-based longitudinal study found that the overall rate of decline accelerated after 40, with the gap between women who started with high versus low levels narrowing as everyone converged toward undetectable values before menopause.9PubMed Central. Back to the basics of ovarian aging: a population-based study on longitudinal anti-Müllerian hormone decline Critically, this study also showed that individual trajectories were highly consistent: a woman’s AMH levels tracked closely along her own personal curve over time, with an intraclass correlation of 0.87. In practical terms, if you get tested at 33 and again at 37, your results will likely follow a predictable personal slope. But the same study highlighted huge variation in AMH levels at any given distance from menopause, meaning two women who are both five years from menopause could have very different absolute AMH numbers.
Can AMH Predict When Menopause Will Happen?
This is one of the most common reasons people look up AMH values. The answer is: somewhat, especially at the extremes. AMH is the single strongest hormonal predictor of time to menopause, outperforming FSH and inhibin B.10PubMed Central. Anti-Mullerian Hormone as a Predictor of Time to Menopause in Late Reproductive Age Women In that study, women aged 35 to 39 with very low AMH (below 0.20 ng/mL) had a median time to menopause of about 10 years, whereas women in the same age group with AMH above 1.50 ng/mL had over 13 years remaining. Adding age to AMH improved prediction accuracy: one study found the combination achieved about 90% predictive accuracy for menopause timing.11The Journal of Clinical Endocrinology & Metabolism. Anti-Müllerian Hormone Predicts Menopause: A Long-Term Follow-Up Study in Normoovulatory Women
Where AMH really shines is in flagging early menopause. An individual-patient-data meta-analysis found that for predicting menopause before age 45, age alone was essentially useless (around 52% accuracy, basically coin-flip territory), but adding AMH boosted accuracy to about 80%. Women in the lowest AMH percentile for their age had roughly a 28% chance of reaching menopause by 45, compared with under 4% for women in the highest percentile.12The Journal of Clinical Endocrinology & Metabolism. Does AMH Relate to Timing of Menopause? Results of an Individual Patient Data Meta-Analysis The same analysis, though, noted that prediction intervals remained wide and did not cleanly separate women heading for very early versus very late menopause. AMH can alert you to risk. It cannot hand you a date.
Low AMH and Premature Ovarian Insufficiency
Premature ovarian insufficiency (POI), where ovarian function drops off well before the typical age of menopause, is one of the main clinical concerns when AMH comes back unexpectedly low in a young woman. Research has found that the risk of POI rises sharply once AMH falls below about 0.5 ng/mL.13PubMed Central. Using anti-Müllerian hormone to predict premature ovarian insufficiency: a retrospective cross-sectional study Low AMH in young women can facilitate earlier diagnosis and prompt earlier conversations about fertility preservation.14PubMed. Can we predict menopause and premature ovarian insufficiency? If you are under 35 and your AMH is well below expected ranges, it is worth discussing with a reproductive endocrinologist rather than dismissing it as a fluke.
High AMH and Polycystic Ovary Syndrome
AMH levels that are unusually high for someone’s age often point toward polycystic ovary syndrome (PCOS). In PCOS, impaired follicle development causes an accumulation of small antral follicles, each pumping out AMH, which drives the total serum level up. There is also evidence that androgens stimulate early follicular growth and further increase AMH production.15PubMed Central. Polycystic Ovary Syndrome (PCOS), Diagnostic Criteria, and AMH AMH plays an inhibitory role in follicle maturation and suppresses the enzyme aromatase, which converts androgens to estrogens. In PCOS, this creates a self-reinforcing cycle: excess AMH contributes to the follicular arrest and hyperandrogenism that define the condition.16PubMed. The role of AMH in the pathophysiology of polycystic ovarian syndrome
An interesting twist is that when women with PCOS undergo IVF, those with the highest AMH levels tend to have worse pregnancy outcomes. One study found that clinical pregnancy rate and live birth rate were significantly higher in PCOS women whose AMH was on the lower end of the elevated range, compared with those whose AMH was extremely high.17PubMed Central. Elevated Anti-Müllerian Hormone as a Prognostic Factor for Poor Outcomes of In Vitro Fertilization in Women with Polycystic Ovary Syndrome Very high AMH may signal more severe follicular dysfunction, not just a larger follicle count.
AMH and Natural Fertility
One of the biggest misconceptions around AMH is that a low number means you cannot conceive naturally. The relationship is real but modest. A prospective cohort study found that women with AMH below 1 ng/mL had about a 23% lower chance of conceiving in a given cycle compared with women whose AMH was in the normal range. But importantly, there was no difference in conception rates between women with high AMH and those with normal AMH.18Fertility and Sterility. Association of anti-Müllerian hormone levels with the time to natural conception: a prospective cohort study One older study even found that women in the low AMH group had a shorter time to pregnancy than the reference group after adjusting for confounders, a counterintuitive result the authors attributed partly to partner factors and the study’s particular population.19PubMed. Anti-Müllerian hormone levels and fecundability in women with a natural conception
The takeaway: AMH is primarily a marker of how many eggs remain, not of egg quality. A 30-year-old with a low AMH may have fewer eggs than average but her eggs are still 30-year-old eggs, with the quality that age implies. A 42-year-old with a robust AMH still faces the age-related decline in egg quality that no blood test can reverse. AMH tells you about quantity. Age tells you more about quality.
How Hormonal Contraceptives Affect Your Results
If you have your AMH tested while using hormonal birth control, the result may be misleadingly low. A cross-sectional study of over 27,000 women found that combined oral contraceptive users had AMH levels roughly 24% lower than women not on contraceptives. Vaginal ring users were about 22% lower, implant users about 23% lower, progestin-only pill users about 15% lower, and hormonal IUD users about 7% lower.20American Journal of Obstetrics and Gynecology. Impact of contraceptives on anti-Müllerian hormone levels: a cross-sectional study of 27,125 women A smaller study confirmed that AMH dropped significantly within nine weeks of starting any combined hormonal method, regardless of whether it was a pill, patch, or ring.21PubMed. Antimüllerian hormone levels decrease in women using combined contraception independently of administration route
This suppression is temporary and reflects the contraceptive’s effect on follicle recruitment, not actual damage to the ovarian reserve. But if you are getting AMH tested specifically to assess your fertility options, the result will underestimate your reserve unless you have been off hormonal contraception for a while. Some clinicians recommend waiting at least two to three months after discontinuing combined methods before drawing AMH for fertility counseling.
Does AMH Fluctuate Within a Cycle?
AMH has long been considered relatively stable compared with other reproductive hormones like FSH, which is why it can be drawn on any day of the menstrual cycle. That is mostly true, but not perfectly so. A meta-analysis found that AMH varies by about 11.5% across the cycle, with levels slightly higher in the follicular phase than the luteal phase.22PubMed Central. Does Anti-Müllerian hormone vary during a menstrual cycle? A systematic review and meta-analysis For most clinical purposes this fluctuation is small enough to ignore, but if your result is right on the border of a clinical cutoff, it could tip the reading one way or the other depending on when in your cycle the blood was drawn.
Lifestyle Factors and Smoking
People often wonder whether diet, exercise, or sleep can move the needle on AMH. The evidence for most lifestyle factors is disappointing: BMI, alcohol, physical activity, and socioeconomic status have not shown a consistent association with age-specific AMH levels in large studies.23The Journal of Clinical Endocrinology & Metabolism. Reproductive and Lifestyle Determinants of Anti-Müllerian Hormone in a Large Population-based Study One study in an Indian population similarly found no correlation with smoking, sleep, diet, BMI, or electronic device use.24PubMed Central. Effect of Reproductive and Lifestyle Factors on Anti-Mullerian Hormone Levels in Women of Indian Origin
The one lifestyle factor that does matter is smoking. The Dutch population study found that current smoking was associated with AMH levels about four percentile points lower than nonsmokers, and smoking also significantly shortened the time to menopause, with a hazard ratio of about 1.6 in the menopause-prediction model.25PubMed Central. Anti-Mullerian Hormone as a Predictor of Time to Menopause in Late Reproductive Age Women The effect was not dose-dependent in the large Dutch study, meaning even light smoking was associated with lower AMH. If there is one modifiable factor that affects ovarian aging, smoking is it.
Racial and Ethnic Differences
AMH reference ranges were historically built from predominantly white populations, but meaningful differences exist across racial and ethnic groups. A review of the evidence found that Black and Hispanic women tend to have lower AMH levels compared with age-matched white women, while Chinese women tend to have higher AMH levels before age 25.26PubMed Central. Ethnicity/Race and Age-Specific Variations of Serum AMH in Women—A Review The rate of decline also differs. One study found that AMH dropped by roughly 10% per year in white, Latina, and Chinese women, but only about 6% per year in African American women, meaning the gap between groups narrowed and eventually reversed at older ages.27PubMed Central. Race/ethnic disparities in reproductive age: An examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly-cycling women
These differences are not just academic. If a Black woman’s AMH is compared to a reference chart built from a white population, her result could look artificially low, potentially triggering unnecessary alarm or overly aggressive fertility treatment. Population-specific reference ranges are slowly becoming available, but many clinics still use one-size-fits-all charts.
AMH in IVF and Ovarian Stimulation
In fertility treatment, AMH is used primarily to predict how the ovaries will respond to stimulation drugs, not to predict whether you will actually get pregnant. Women with higher AMH produce more eggs during a cycle, and those with lower AMH produce fewer. One study found that pregnancy rates per IVF cycle rose from about 15% in low responders to roughly 45% in high responders, closely tracking AMH levels.28PubMed Central. Cut-Off Levels of Anti-Mullerian Hormone for The Prediction of Ovarian Response, In Vitro Fertilization Outcome and Ovarian Hyperstimulation Syndrome
At the other end of the spectrum, very high AMH raises the risk of ovarian hyperstimulation syndrome (OHSS), a potentially dangerous overreaction to stimulation drugs. A consensus study identified an AMH threshold of about 4.4 ng/mL as the point above which clinicians should exercise increased caution with dosing, and in women over 35, that threshold was slightly lower at around 4.3 ng/mL.29PubMed. Antimüllerian hormone and antral follicle count thresholds for hyperresponse risk assessment in in vitro fertilization: a Hyperresponse Risk Assessment consensus study These thresholds help fertility clinics individualize medication protocols rather than relying on one-size-fits-all dosing.
Chemotherapy and Medical Impacts on AMH
Gonadotoxic treatments such as chemotherapy can cause dramatic drops in AMH. A study of breast cancer patients found that AMH levels were already lower before chemotherapy began (compared with healthy controls) and then fell further after treatment.30PubMed Central. Chemotherapy: Impact on Anti-Müllerian Hormone Levels in Breast Carcinoma The degree of damage depends on the drug and dose, but many chemotherapy regimens accelerate the depletion of the primordial follicle pool, leading to premature loss of ovarian function.
This is an active area of therapeutic research. Animal studies have shown that giving recombinant AMH alongside chemotherapy can protect the primordial follicle pool by keeping dormant follicles from being prematurely activated and destroyed. In mouse models, co-administration of AMH with common chemotherapy agents preserved significantly more primordial follicles and improved long-term fertility outcomes without interfering with the cancer-fighting effects of the drugs.31PubMed Central. Pharmacological administration of recombinant human AMH rescues ovarian reserve and preserves fertility in a mouse model of chemotherapy, without interfering with anti-tumoural effects 32PubMed Central. AMH/MIS as a contraceptive that protects the ovarian reserve during chemotherapy This has not yet reached human clinical trials, but the concept that AMH itself could be used as a protective therapy is a genuinely novel direction in fertility preservation.
Assay Differences Can Muddy the Picture
Not all AMH tests give identical results for the same blood sample. Multiple commercial assays are available, and they use different calibration standards, which introduces variability between labs and test platforms.33PubMed Central. Variation in the Measurement of Anti-Müllerian Hormone – What Are the Laboratory Issues? Newer versions of common assays have been reported to read 30 to 40% higher than older versions for the same sample.34American Journal of Obstetrics and Gynecology. Contemporary ovarian reserve tests: a review – Section: Age-specific AMH values This means comparing an AMH result from one lab in 2018 with a result from a different lab in 2024 is not straightforward. If you are tracking AMH over time, try to use the same lab and assay each time, and make sure your clinician knows which platform was used.
AMH in Males
Although AMH testing is primarily associated with women’s fertility, the hormone plays a major role in male biology, particularly during development. AMH is produced by Sertoli cells in the testes and is present at high levels from fetal life through childhood, serving as a marker of Sertoli cell function.35PubMed. Anti-müllerian hormone and sertoli cell function in paediatric male hypogonadism Before puberty, boys have substantially higher AMH than girls. Once testosterone levels rise during puberty, AMH drops sharply, and postpubertal males end up with levels that overlap with female levels, though the male median remains about two to three times higher.36The Journal of Clinical Endocrinology & Metabolism. Clinical Utility of Anti-Mullerian Hormone in Pediatrics – Section: Physiological Role of AMH In pediatric medicine, AMH is used to evaluate conditions like cryptorchidism (undescended testes) and disorders of sex development, where it helps confirm whether functional testicular tissue is present. Research into using AMH to predict surgical sperm recovery in adult men is ongoing but still early.37The Innovation. Clinical Applications of Serum Anti-Müllerian Hormone Measurements in Both Males and Females: An Update
Seasonal Variation in Other Species
The biology of AMH extends well beyond humans. In seasonal breeders, AMH levels fluctuate with reproductive cycles in ways that do not occur in humans. A study of squirrel monkeys found that male AMH was significantly higher during the breeding season (averaging about 4.2 ng/mL) compared with the non-breeding season (about 2.8 ng/mL).38PubMed. Presence of anti-müllerian hormone in the squirrel monkey (Saimiri boliviensis): gender and seasonal differences While this has no direct clinical application for humans, it underscores that AMH is not a static structural protein but an active hormonal signal that organisms modulate in response to reproductive demands. Understanding AMH across species has helped researchers identify its broader role in regulating follicle activation and gonadal function, ideas that are now feeding back into human fertility research, including the experimental chemotherapy-protection work described above.